rituximab

navigate by keyword : antibody antigen arthritis autoimmune bcell biological biosimilar biotech biotechnology blood blymphocyte cancer cd20 cell chronic disease drug idiopathic immunoglobulin immunology infusion injection inn leukemia lupus lymphocytic lymphoma mab malignant monoclonal multiple nomenclature nonhodgkin pemphigus peptide protein purpura rheumatoid rituximab sclerosis thrombocytopenic transplant vulgaris white

B-lymphocyte antigen CD20 epitope peptide fragment, bound to rituximab (Fab fragment). Indications for rituximab include leukemia Royalty Free Stock Photo
Pseudo-Pelger-Huet anomaly acquired (Rituximab). Royalty Free Stock Photo
Pseudo-Pelger-Huet anomaly acquired (Rituximab). Royalty Free Stock Photo
Pseudo-Pelger-Huet anomaly acquired (Rituximab). Royalty Free Stock Photo
Pseudo-Pelger-Huet anomaly acquired (Rituximab). Royalty Free Stock Photo
B-lymphocyte antigen CD20 (theoretical model). Protein expressed on the surface of B-cells. Anti-CD20 monoclonal antibody drugs Royalty Free Stock Photo
B-lymphocyte antigen CD20 (theoretical model). Protein expressed on the surface of B-cells. Anti-CD20 monoclonal antibody drugs Royalty Free Stock Photo
Rituximab monoclonal antibody drug. Targets CD20 on B-lymphocytes. Indications for use indicate rheumatoid arthritis and a number
Pseudo-Pelger-Huet anomaly acquired (Rituximab). Royalty Free Stock Photo
B-lymphocyte antigen CD20 epitope peptide fragment, bound to rituximab (Fab fragment). Indications for rituximab include leukemia Royalty Free Stock Photo
B-lymphocyte antigen CD20 (theoretical model). Protein expressed on the surface of B-cells. Anti-CD20 monoclonal antibody drugs Royalty Free Stock Photo
B-lymphocyte antigen CD20 epitope peptide fragment, bound to rituximab (Fab fragment). Indications for rituximab include leukemia Royalty Free Stock Photo
B-lymphocyte antigen CD20 epitope peptide fragment, bound to rituximab (Fab fragment). Indications for rituximab include leukemia Royalty Free Stock Photo
B-lymphocyte antigen CD20 epitope peptide fragment, bound to rituximab (Fab fragment). Indications for rituximab include leukemia Royalty Free Stock Photo
B-lymphocyte antigen CD20 epitope peptide fragment, bound to rituximab (Fab fragment). Indications for rituximab include leukemia Royalty Free Stock Photo
Rituximab monoclonal antibody drug. Targets CD20 on B-lymphocytes. Indications for use indicate rheumatoid arthritis and a number of leukemias and lymphomas. Generic name and stylized antibody representation


Stockphotos.ro (c) 2025. All stock photos are provided by Dreamstime and are copyrighted by their respective owners.